Targeted Structural Properties
Enzyme modification aims to produce $\text{HA}$ with a controlled degree of branching and polymer length , matching specific bioactivity requirements.
Beta-Glucan (ß-Glucan) is a high-value polysaccharide recognized for its immunomodulatory, cholesterol-lowering, and prebiotic properties, driving demand in the health supplements and food industries. Traditional production methods, such as fungal extraction, result in low efficiency of fungal extraction and often require harsh chemicals. While microbial fermentation is a cleaner alternative, it frequently yields a product with insufficient purity , as the Beta-Glucan remains bound to other cell wall components.
CD Biosynsis offers a synthetic biology service focused on the Saccharomyces cerevisiae (Brewer's yeast) chassis. Our core strategy involves the modification of glucan synthase in Saccharomyces cerevisiae to enhance its activity and potentially control the structural characteristics (e.g., degree of branching) of the resulting ß-Glucan. This is complemented by the optimization of post-fermentation purification processes to achieve high purity levels suitable for sensitive applications. This integrated approach aims to deliver a high-yield, structurally tailored, and contaminant-minimized ß-Glucan product.
Get a QuoteScaling up high-purity Beta-Glucan production is challenging due to:
A successful solution must combine enhanced biosynthesis with simplified, high-efficiency recovery.
CD Biosynsis applies strain engineering and process optimization to address Beta-Glucan production issues:
Modification of Glucan Synthase in Saccharomyces cerevisiae
We employ gene editing and directed evolution of glucan synthase to potentially tune the ratio of beta-(1,3) to beta-(1,6) linkages and control the polymer length, tailoring bioactivity.
Optimization of Post-Fermentation Purification Processes
We develop and optimize new extraction and purification protocols focused on minimizing co-purification of cell wall debris and proteins , targeting ultra-high purity.
Enhanced Export and Release Engineering
We modify cell wall synthesis genes to facilitate the easier release of ß-Glucan into the medium or simplify its liberation during mild downstream processing.
Precursor Metabolism Tuning
We engineer the host's central carbon metabolism to maximize the supply of $\text{UDP-Glucose}$ , the essential precursor for glucan synthase activity.
This systematic approach is focused on overcoming structural heterogeneity and downstream purification complexity for high-grade ß-Glucan.
Our Beta-Glucan engineering service is dedicated to pursuing the following production goals:
Targeted Structural Properties
Enzyme modification aims to produce $\text{HA}$ with a controlled degree of branching and polymer length , matching specific bioactivity requirements.
Ultra-High Purity Potential
Optimized purification protocols are focused on achieving purity levels suitable for sensitive pharmaceutical or nutraceutical applications .
Enhanced Extraction Efficiency
Host engineering to facilitate release aims to reduce the harshness and duration of extraction steps , improving overall yield.
Safer, Consistent Supply
Microbial fermentation offers a highly reproducible, non-animal-derived source , reducing variability and safety concerns.
Cost Reduction Potential
High yield and efficient purification are focused on lowering the overall cost of the final ß-Glucan product. [Image of Cost Reduction Icon]
We provide a biosynthetic platform aimed at maximizing the quality and cost-effectiveness of Beta-Glucan production.
Our Beta-Glucan strain engineering service follows a standardized, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding structural characteristics and purity.
Explore the potential for tailored, high-purity Beta-Glucan production. CD Biosynsis provides customized strain and process engineering solutions:
What makes the structure of Beta-Glucan so important?
The bioactivity, particularly the immunomodulatory effect , is strongly linked to the structure. Specifically, beta-(1,3) linkages form the backbone, while beta-(1,6) linkages create side branches. The density and length of these branches determine how effectively the molecule interacts with immune receptors.
Why is Saccharomyces cerevisiae a preferred host?
S. cerevisiae (Baker's yeast) is an FDA-approved Generally Recognized as Safe (GRAS) organism. It naturally synthesizes ß-Glucan in its cell wall and offers a well-understood genetic system, making it ideal for engineered food and supplement ingredients.
What causes the low purity in fermentation?
In yeast, ß-Glucan is a major structural component of the cell wall, intimately associated with chitin, mannan, and proteins . The difficulty lies in breaking the cell wall open and separating the target ß-Glucan without co-extracting these contaminants.
How can you enhance the extraction efficiency?
We can utilize genome editing to weaken or modify non-essential cell wall components (like reducing chitin content). This aims to make the cell wall more susceptible to milder lysis or extraction protocols, increasing the yield and lowering costs.
What is the estimated project timeline?
A project involving glucan synthase engineering and integrated purification optimization typically requires 22-26 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.